Previous 10 | Next 10 |
Co-Diagnostics press release ( NASDAQ: CODX ): Q3 GAAP EPS of -$0.04. Revenue of $5.1M (-83.1% Y/Y). For further details see: Co-Diagnostics GAAP EPS of -$0.04, revenue of $5.1M
Co-Diagnostics, Inc. Reports Third Quarter 2022 Financial Results PR Newswire Nearing commencement of clinical evaluations for the Co-Dx PCR Home platform COVID-19 test volumes continue to impact third quarter results SALT LAKE CITY , Nov. 10, 2...
Co-Diagnostics ( NASDAQ: CODX ) is scheduled to announce Q3 earnings results on Thursday, November 10th, after market close. The consensus EPS Estimate is -$0.03 and the consensus Revenue Estimate is $7.48M (-75.1% Y/Y). Over the last 1 year, CODX has beaten EPS esti...
Co-Diagnostics, Inc. to Host Booth at AMP This Week in Phoenix, AZ PR Newswire SALT LAKE CITY , Nov. 3, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patente...
Co-Diagnostics, Inc. Appoints Dr. Mark Poritz as New Chief Scientific Officer PR Newswire SALT LAKE CITY , Nov. 1, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company with a...
CO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST PR Newswire SALT LAKE CITY , Oct. 27, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for t...
Co-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa PR Newswire SALT LAKE CITY , Oct. 26, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a ...
Co-Diagnostics, Inc. to Host Booths at Conferences in Washington, D.C. and Bangkok, Thailand PR Newswire SALT LAKE CITY , Oct. 19, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics com...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips As people acclimatize to the new normal, it’s time to look at some vaccine stocks to sell. Instead of relying primarily on vaccines and antiviral drugs, the government let people manage infections. Once infected wi...
Co-Diagnostics, Inc. to Sponsor, Present, and Host Booth at 66th Annual CARPHA Conference on Sept 15-17 in Jamaica PR Newswire SALT LAKE CITY , Sept. 14, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecul...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...